TGFB1 and neoplasm: An investigation of the correlations between LAMP2 expression and tumor molecular subtypes and immune subtypes based on TISIDB showed that LAMP2 expression was meaningfully linked with several different immune subtypes (C1: wound healing, C2: IFN-gamma dominant, C3: inflammatory, C4: lymphocyte depleted, C5: immunologically quiet, and C6: TGF-b dominant) in five cancer types (Figure 14A): BLCA (Figure 14B), BRCA (Figure 14C), LIHC (Figure 14D), STAD (Figure 14E), and TGCT (Figure 14F).